2020

Pharmacologic Interventions for Improving Outcomes after Peripheral Nerve Injury: Leupeptin and Indinavir

Visit USCO

Text Registration

Pharmacologic Interventions for Improving Outcomes after Peripheral Nerve Injury: Leupeptin and Indinavir

Status

Published

on 28 Sept 2020

Year of Creation

2020

Mikhail Gurevich

Registration Number

TX0008919368

on 28 Sept 2020

The U.S. Copyright record (Registration Number: TX0008919368) dated 28 Sept 2020, pertains to an electronic file (eService) titled "Pharmacologic Interventions for Improving Outcomes after Peripheral Nerve Injury: Leupeptin and Indinavir" created in 2020. The copyright holder is Mikhail Gurevich, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Mikhail Gurevich.

Mikhail Gurevich

Application Details

Registration Number

TX0008919368

Registration Date

9/28/2020

Year of Creation

2020

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Mikhail Gurevich

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Pharmacologic Interventions for Improving Outcomes after Peripheral Nerve Injury: Leupeptin and Indinavir

Author Statement: Mikhail Gurevich Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Pharmacologic Interventions for Improving Outcomes after Peripheral Nerve Injury: Leupeptin and Indinavir

Author Statement: Mikhail Gurevich Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.